{"name":"CV Technologies","slug":"cv-technologies","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"CVT-E002 ginseng extract","genericName":"CVT-E002 ginseng extract","slug":"cvt-e002-ginseng-extract","indication":"Atrial fibrillation for stroke prevention","status":"phase_2"}]}],"pipeline":[{"name":"CVT-E002 ginseng extract","genericName":"CVT-E002 ginseng extract","slug":"cvt-e002-ginseng-extract","phase":"phase_2","mechanism":"CVT-E002 ginseng extract is an herbal supplement that may help improve cardiovascular health by reducing inflammation and improving blood flow.","indications":["Atrial fibrillation for stroke prevention"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxQazFZUXBjSXJmR0MweklLUl81MEx0U1BQNkR5OXh2eHoySDNPVHpPOEdqc3pxRkYzLXg5d1FLYXd3LUMtN1pHaFVLd2lOajBCNVlrZ3VIV3lfaTBZcUdqRDJOTXRvRDlPQ3oxTkJQcGR0U0pJbGhhUkpBd1NOWmkxcjdOX2JDUlN3elVmX1NDbEVlYWJ1?oc=5","date":"2026-03-12","type":"pipeline","source":"Cleanroom Technology","summary":"Upperton Pharma Solutions submits MHRA application for new sterile manufacturing facility - Cleanroom Technology","headline":"Upperton Pharma Solutions submits MHRA application for new sterile manufacturing facility","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwJBVV95cUxONlU2LVZIeGpLdGVKTGxxZ2lCYXFOT3R4VXM4STF6S2pfZnRxT1lNRlFseUtxQzlTa0tQckZzZWEtbktfM1d1TUo3cnhMU1F1QzhfNVJXVUh0STJpYVprb0ZOM21mT3U0NDhyQktZWl84UGZzSDg3bHJXOThfTm5mbndfZks2N3V0VDlmaURHa3NXTUhQUGpHblFYU0Foem1LR3NBODVDVmlXbHJvV0Y1N05SWEcybDBfWVRjeFc5THlQeGRwQUNkMkVBd200RHVvbE9jMWlQWWZXM3pCZTJMNUtGVHRzLXZWSWlqZUVrd2dDSFVKUE5TaXlKakcxaDN4Y0hZUHM5eXRxeWt2X3UwUVZyUUFwZ21EUVdJMzAxTQ?oc=5","date":"2026-01-30","type":"earnings","source":"NDTV Profit","summary":"Tata Motors CV, Dixon, Canara Bank, Lodha Developers, Phoenix Mills, Balkrishna Industries, Voltas, Star Health, Piramal Pharma, V-Guard And More Q3 Review By HDFC Securities — Check Ratings - NDTV Pr","headline":"Tata Motors CV, Dixon, Canara Bank, Lodha Developers, Phoenix Mills, Balkrishna Industries, Voltas, Star Health, Piramal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxOQlZhN0dCc0htUEhhUVJiT2FNZDlnOWlUSF9lWlNWUDBwWmZMVl9vQXFfUWlBU25qWXFwUGVzRXROZDZlaHVLU043TFJjUGtyV3dILUxGY0Y2Vlltdk9qMW8zbFB1amdRUnNyVk5yeEU5Y2tjaDBHeWRZMDExMHRDYdIBlAFBVV95cUxPRmhPbG9QdVg2THNLZzZHOTlhQW82aVVoa0xpLTE1TWN6azN5dTBEUUxmZFpmRFE0RDNIdlhibXFiRjQzbTJjZm5CVjJJQlh5MlNWY2hENk9BbEdqU2R2bk10eDNldnZMeFAwUDdXZ3JfTjJHZmR0NFp6Tmp6SXlfdHN0RnRtQXY3ZzV6Wno0c1VfX250?oc=5","date":"2025-12-15","type":"pipeline","source":"Chosunbiz","summary":"Cureverse exports oral dementia drug technology worth 500 billion won, aims for KOSDAQ listing in 2027 - CHOSUNBIZ - Chosunbiz","headline":"Cureverse exports oral dementia drug technology worth 500 billion won, aims for KOSDAQ listing in 2027 - CHOSUNBIZ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxQN2JfVkx0ODFHbDVlZ1FuVkxrSHFSUXJxNC1hLS12UTlyOWZoM3pJNzBSblVHVFFNZkVfZ3p4UUR6VlBBaFJsNVF6QWpGNjNpclQ5T1JzZEFHSzlJcEtvRDlZNUp4Y2IyVDFXeUk3Q29TV2dCSVdxYU5vcWFDei1MR0VwcE00TVBCaG9pbk9yN0UyVXNHX3V4VERuVG1pU3hWV2FENi1xeW1zMDZaam5wU0tpTnNUQUFpamtr0gFyQVVfeXFMTlMxWmtoYThfUlIzMm1uOXRGbERSU2c2dGV4WWRpMWpJcE9DQkxpSk42TVNkVFI5Q21pN3FrX1lVcGw2c3FRODcxVmFJRHNLUl9VWWplSnZaRmgtRmo1SnZMOHljRk0tZUJxeWVfQlpiek9R?oc=5","date":"2025-11-25","type":"pipeline","source":"Law360","summary":"Judge Hands SEC Win In Pharma Co.'s CBD Investor Fraud Case - Law360","headline":"Judge Hands SEC Win In Pharma Co.'s CBD Investor Fraud Case - Law360","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-11-12","type":"pipeline","source":"Business Standard","summary":"Stock Alert: PI Industries, IOL Chemicals & Pharma, Awfis Space Sol, Zaggle Prepaid - Business Standard","headline":"Stock Alert: PI Industries, IOL Chemicals & Pharma, Awfis Space Sol, Zaggle Prepaid","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxQQlVFTlNiNXFIV3R2MlB0RmRwZ1h4THV1TW5xMUxRN18yMVl0c0pldFp0X3hGSDI5bnQzQUpYWjhpSGR1WlluM01NRTdFalJRSGZTRmp0ZWRaeVV2ekR3VjZrZmNGUEd1a3BFZEFQVk1tVUR3TWxMR01KOGozb0tEZERxSk5EVTVOMVJyTHVkNHZpWGZFbU1jdlllNVVPeTlMMm1vbWI0Qjg5UFdEcGJTekpmMUhZUmdzVldEbw?oc=5","date":"2025-11-06","type":"pipeline","source":"Pharmaceutical Technology","summary":"Novo Nordisk’s oral Wegovy reduces cardiovascular risk factors in obesity - Pharmaceutical Technology","headline":"Novo Nordisk’s oral Wegovy reduces cardiovascular risk factors in obesity","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5wFBVV95cUxPb3JRdWQ4U29RRS1UQU0tcGxIVlFQQWRXZDFaSFBKT1RSby1aSWZLOE1oZzFQc25laEZoNkxtWlJ5Zm1CVmZWb1otNU9LOXg0TFVqUWpBejZGejc2aE9uTU01SXV4ZGk3dFBEU3RVU0VHUC03MFcxakk4Q0NSeHp0dUgwczhoNk9NWmdySmFRSGFKZE1ROVQyVEV3U3V0U3hJVDhqcmt4UFZkTGZQbnh6eF9iLXRKbDY0bzdmYmJDRHhZM3BPUjBuX1QyczhhMElfb19yTUFUSU9jNWFQeU54QzlrMktybUk?oc=5","date":"2025-10-22","type":"pipeline","source":"businesswire.com","summary":"IFA Celtics: Mexico’s First Pharmaceutical Company to Deploy ForgeStop's NFC Anti-Counterfeit Tech - businesswire.com","headline":"IFA Celtics: Mexico’s First Pharmaceutical Company to Deploy ForgeStop's NFC Anti-Counterfeit Tech","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxQaE5qVkZEbkhVRTNjellSOVphd25McXdkaUtKVWxlMmJWZDBkTTRabGpiWk9LWDJZUWVyX0VYQzBRc3FEdWRIcVNTX01tVWJaTVlJVlhvc1NQSFA2QUhrQVE2N3daQWZlNWlfLTVhV2ZHQUtCYzBfUnZzQm1mYVpFWUI3c2VXaUE?oc=5","date":"2025-09-29","type":"pipeline","source":"intlbm","summary":"ADIA Invests in CV by GL Capital’s Pharmaceuticals - intlbm","headline":"ADIA Invests in CV by GL Capital’s Pharmaceuticals","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-09-27","type":"patent","source":"Medical Dialogues","summary":"Patent infringement: Factor Bioscience sues AstraZeneca, Cellectis over gene-editing technology - Medical Dialogues","headline":"Patent infringement: Factor Bioscience sues AstraZeneca, Cellectis over gene-editing technology","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTFBsdFBhV3JBeGNiMDJvWTZjMjRHbk90c19QVUd3U3pVUDJfR2ZBMlNvWlZCTXpPVzJaM3MySmhuUEdMQ2dYS1VENU81eFdvUnNBdEUw?oc=5","date":"2025-09-02","type":"pipeline","source":"FirstWord Pharma","summary":"Corsera Health combines RNAi, AI tech to create 'a world without cardiovascular disease' - FirstWord Pharma","headline":"Corsera Health combines RNAi, AI tech to create 'a world without cardiovascular disease'","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxPektjZVl6MmR6ZmFCN2VrYUhUQU13RzM1ZUctWmR1N054Q3VEWjZZX0JWYkNVeXQ3TUJWUHFjZmRoNUdzRXJualcxbHBwVGZINXBLZ3lURmFCRG5ZNTNsd19MV0U5c05ady13ZWVVOW40Y1hvdFNKbHNGWEhVQ0xTWFRHQXRUdWRiUjl0a2tTWnUwanBIVWRPd29MS3oxdnA2VmlWRUhuZ0xrSWhzaHA0ZnRZOFVEVkUtZ3lDcQ?oc=5","date":"2025-09-01","type":"pipeline","source":"Pharmaceutical Technology","summary":"ESC 2025: Novo Nordisk’s Wegovy superior to Zepbound in reducing CV events - Pharmaceutical Technology","headline":"ESC 2025: Novo Nordisk’s Wegovy superior to Zepbound in reducing CV events","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxOSDNQeGc0UWdCdXEwbEg0VTd0ZlY4bkl5QmFwRXB6Z210WXRrWDZic3Z0VDFVOFVURjhGUHpmNlp1RTViWlc0dnZtM043ZERUSURiUjRkNzVFdzRsZ1VGbDNaWFc3R251VmpsR2lwVzlUYm8tWTRhSW1LSFVjSE83RjRSbkI0bEVuMTJTeWpB?oc=5","date":"2025-06-14","type":"pipeline","source":"Santa Clarita Valley Signal","summary":"COC Pharmacy Technology Program enrolling first cohort - Santa Clarita Valley Signal","headline":"COC Pharmacy Technology Program enrolling first cohort","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}